🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 53 of 78

  1. US 7915396

    Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7915040

    Defensin-antigen fusion proteins

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7915036

    Compositions comprising T cell receptors and methods of use thereof

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7914788

    Monoclonal antibodies against orthopoxviruses

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7914801

    Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7910692

    Immunogenic peptides and methods of use

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7910105

    Methods for treating and preventing fibrosis

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7906292

    Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7902441

    Chromosome 3p21.3 genes are tumor suppressors

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7902348

    Janus family kinases and identification of immune modulators

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7902228

    Schweinfurthin analogues

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7897152

    Viral chemokine-antigen fusion proteins

    Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7897575

    Treatment and prevention of vascular dementia

    Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7897355

    Gene expressed in prostate cancer and methods of use

    Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7892786

    Methods for expression and purification of immunotoxins

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7892569

    Methods of altering an immune response induced by CpG oligodeoxynucleotides

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7892738

    Pot1 alternative splicing variants

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7888069

    Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7887818

    Neospora caninum vaccine

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7887812

    Live attenuated Leishmania vaccines

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7888070

    Nucleic acids encoding growth hormone with a modified RSP sorting signal

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7888116

    Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7883710

    Peptide vaccines against Group A streptococci

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7884178

    Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7879810

    Immunostimulatory nucleic acid molecules

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7879909

    Use of Treprostinil to treat neuropathic diabetic foot ulcers

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7875262

    Aqueous starch-oil dispersions having improved UV stability and absorbing ability

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7875450

    Virus-like particles for the induction of autoantibodies

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7871986

    Methods of stimulating an immune response against prostate specific antigen

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7872110

    Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7871981

    Inhibition of cell motility, angiogenesis, and metastasis

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7867500

    Cofactor that modulates steroid receptor activities

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7867983

    Methods to protect skeletal muscle against injury

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7867974

    Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7867977

    Immunogenic peptides and methods of use for treating and preventing cancer

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7863262

    Nitroxyl progenitors in the treatment of heart failure

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7862815

    Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7863041

    Rabies virus vector systems and compositions and methods thereof

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7855076

    Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7855276

    Framework residue substituted humanized COL-1 antibodies and their use

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7851194

    West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7851169

    Compositions and methods for inhibiting squamous cell carcinoma

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7846454

    Cloned genomes of infectious hepatitis C viruses and uses thereof

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7846675

    Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7846455

    Attenuated chimeric respiratory syncytial virus

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7846450

    Melanoma associated peptide analogues and vaccines against melanoma

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7842729

    Anti tubercular drug: compositions and methods

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7842798

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.